MX367294B - Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica. - Google Patents

Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica.

Info

Publication number
MX367294B
MX367294B MX2013010937A MX2013010937A MX367294B MX 367294 B MX367294 B MX 367294B MX 2013010937 A MX2013010937 A MX 2013010937A MX 2013010937 A MX2013010937 A MX 2013010937A MX 367294 B MX367294 B MX 367294B
Authority
MX
Mexico
Prior art keywords
staging
liver fibrosis
early diagnosis
vitro test
fibrosis
Prior art date
Application number
MX2013010937A
Other languages
English (en)
Other versions
MX2013010937A (es
Inventor
Del Carmen García De Léon Méndez María
Hernández Cequera Alains
Original Assignee
Univ Mexico Nac Autonoma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mexico Nac Autonoma filed Critical Univ Mexico Nac Autonoma
Priority to MX2013010937A priority Critical patent/MX367294B/es
Priority to PCT/MX2014/000147 priority patent/WO2015047071A1/es
Publication of MX2013010937A publication Critical patent/MX2013010937A/es
Publication of MX367294B publication Critical patent/MX367294B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
    • G01N2333/918—Carboxylic ester hydrolases (3.1.1)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/08—Hepato-biliairy disorders other than hepatitis
    • G01N2800/085—Liver diseases, e.g. portal hypertension, fibrosis, cirrhosis, bilirubin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un papel de proteínas aisladas para la detección y estatificación el proceso fibrótico hepático en un paciente con enfermedad hepática crónica, caracterizado porque consiste de las proteínas: MFAP-4, FBN1, ALDH1A3, CYP26A1; MGP, C7 y PLA2G7.
MX2013010937A 2013-09-24 2013-09-24 Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica. MX367294B (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2013010937A MX367294B (es) 2013-09-24 2013-09-24 Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica.
PCT/MX2014/000147 WO2015047071A1 (es) 2013-09-24 2014-09-24 Prueba in vitro para diagnóstico temprano y estadificación de fibrosis hepática

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2013010937A MX367294B (es) 2013-09-24 2013-09-24 Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica.

Publications (2)

Publication Number Publication Date
MX2013010937A MX2013010937A (es) 2015-03-24
MX367294B true MX367294B (es) 2019-08-05

Family

ID=52744063

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013010937A MX367294B (es) 2013-09-24 2013-09-24 Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica.

Country Status (2)

Country Link
MX (1) MX367294B (es)
WO (1) WO2015047071A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106771201A (zh) * 2016-12-05 2017-05-31 江西惠肽生物科技有限公司 用于肝纤维化诊断试剂盒及其检测方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE354097T1 (de) * 2004-08-12 2007-03-15 Hoffmann La Roche Verfahren zur diagnose von leberfibrose.
ES2457243T3 (es) * 2006-09-08 2014-04-25 The Chancellor, Masters And Scholars Of The University Of Oxford Diagnóstico clínico de una fibrosis hepática utilizando APOL1 de suero humano como biomarcador

Also Published As

Publication number Publication date
WO2015047071A1 (es) 2015-04-02
MX2013010937A (es) 2015-03-24

Similar Documents

Publication Publication Date Title
MX2015015784A (es) Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino.
MX2019015159A (es) Composiciones, metodos y usos para asistir en el diagnostico, pronostico y tratamiento de la fibrosis pulmonar idiopatica.
EP2814429A4 (en) METHOD AND DEVICE FOR COUPLING A FLUTE PROSTHESIS WITH TISSUE
MX2013002084A (es) Biomarcadores y metodos de tratamiento.
IL282923A (en) Methods and preparations for the diagnosis and treatment of disorders in patients with high levels of chemokine C.-X.-C. Ligand 9 and other biomarkers
IL246917A0 (en) Biomarker and early diagnosis methods for Alzheimer's disease
EP4356960A3 (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions
IN2014DN06898A (es)
MX2014006130A (es) Metodos de diagnostico y tratamiento de la fibrosis pulmonar idiopatica.
MX2022010809A (es) Antagonistas de integrina-beta7 para usarse en el tratamiento y diagnostico de trastornos inflamatorios gastrointestinales.
MX2015013166A (es) Proteinas de union especificas duales dirigidas contra il-1 beta y/o il-17.
NZ707035A (en) Gene signatures of inflammatory disorders that relate to the liver
NZ723884A (en) Methods of treating alzheimer’s disease
UY34243A (es) Marcadores y metodos para evaluación del riesgo de enfermedades cardiovasculares
WO2013040251A3 (en) Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
WO2014078468A3 (en) Biomarkers for predicting clinical response of cancer patients to treatment with immunotherapeutic agent
WO2015187727A3 (en) Molecular mammography
EP3218481A4 (en) Biomarkers useful in the treatment of subjects having diseases of the eye
IN2014DN06662A (es)
WO2013106766A3 (en) THERAPEUTIC INDICATIONS OF miR-1291
WO2014169011A3 (en) Methods for treating immune diseases
HUE037004T2 (hu) Szterolszármazékok és felhasználásuk transzformált asztrocitasejtekkel kapcsolatos betegségek vagy malignus hemopátiák kezelésére
MX367294B (es) Prueba in vitro para diagnostico temprano y estadificacion de fibrosis hepatica.
WO2015092435A3 (en) Conjugates for treating inflammatory disease and identification of patients likely to benefit from such treatment
Walsh Re: Disease-specific survival of men with prostate cancer detected during the screening interval: results of the European Randomized Study of Screening for Prostate Cancer-Rotterdam after 11 years of follow-up

Legal Events

Date Code Title Description
FG Grant or registration